Gregory L. Weaver is Director at ATOSSA THERAPEUTICS, INC. (ATOS). They have made 18 open-market trades across 9 companies since 2006, most recently 2026-07-31.
CIK 0001251779
15 open-market purchases totalling $507K since 2006, against 3 sales. Across 11 scored buys the stock is up 5.9% at ninety days, and 2.3 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 27% | 27% | 27% |
| Avg Move | -7.9% | -0.3% | +5.9% |
| Alpha | -5.4% | -1.7% | +2.3% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALT | BUY | 2026-04-01 | 2026-04-01 | $3.15 | $31K | +6.1% | -9.5% | -2.1% |
| ALT | BUY | 2026-03-06 | 2026-03-09 | $3.54 | $18K | -12.3% | -13.6% | -29.7% |
| ALT | BUY | 2025-03-13 | 2025-03-14 | $5.20 | $52K | -5.6% | -21.8% | +20.8% |
| ATOS | SELL | 2023-11-15 | 2023-11-17 | $0.65 | $33K | +9.6% | +6.2% | +49.0% |
| ATOS | BUY | 2023-06-20 | 2023-06-20 | $0.97 | $49K | +31.3% | +18.8% | -17.1% |
| ATOS | SELL | 2021-07-02 | 2021-07-07 | $5.58 | $1.2M | -26.2% | -36.0% | -41.3% |
| ATAI | BUY | 2021-06-22 | 2021-06-24 | $15.00 | $70K | -0.8% | -7.9% | -7.4% |
| ELOX | BUY | 2018-03-23 | 2018-03-26 | $8.56 | $39K | +29.6% | +12.1% | +82.1% |
| ATOS | BUY | 2013-11-21 | 2013-11-22 | $2.58 | $26K | -15.6% | +20.0% | +20.0% |
| FCSC | BUY | 2013-11-20 | 2013-11-20 | $3.51 | $35K | -33.7% | -1.8% | -1.8% |
| CLSN | SELL | 2013-03-19 | 2013-03-21 | $1.06 | $40K | -28.5% | +0.0% | +0.0% |
| CLSN | BUY | 2011-12-06 | 2011-12-07 | $2.15 | $11K | -28.5% | +0.0% | +0.0% |
| CLSN | BUY | 2011-05-26 | 2011-05-31 | $2.77 | $24K | -28.5% | +0.0% | +0.0% |
| CLSN | BUY | 2010-09-16 | 2010-09-16 | $3.10 | $16K | -28.5% | +0.0% | +0.0% |
| PARD | BUY | 2009-08-21 | 2009-08-21 | $7.39 | $22K | N/A | N/A | N/A |
| PARD | BUY | 2009-04-06 | 2009-04-06 | $2.07 | $4K | N/A | N/A | N/A |
| CLN | BUY | 2007-02-23 | 2007-02-27 | $3.50 | $35K | N/A | N/A | N/A |
| RNAI | BUY | 2006-05-25 | 2006-05-25 | $5.06 | $76K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| PARD |
| 10,000 |
| — |
| RNAI | 15,000 | — |
| Total | $373K |
Shares reported on the most recent Form 4, priced at the 2026-08-03 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.